During the last session, Diversified Healthcare Trust (NASDAQ:DHC)’s traded shares were 0.61 million, with the beta value of the company hitting 1.99. At the end of the trading day, the stock’s price was $2.68, reflecting an intraday gain of 2.29% or $0.06. The 52-week high for the DHC share is $4.24, that puts it down -58.21 from that peak though still a striking 25.0% gain since the share price plummeted to a 52-week low of $2.01. The company’s market capitalization is $646.61M, and the average trade volume was 1.09 million shares over the past three months.
Diversified Healthcare Trust (DHC) received a consensus recommendation of Strong Sell from analysts. That translates to a mean rating of 5.00. DHC has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 0 recommend a Buy rating for it. 1 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.25.
Diversified Healthcare Trust (NASDAQ:DHC) trade information
Diversified Healthcare Trust (DHC) registered a 2.29% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 2.29% in intraday trading to $2.68, hitting a weekly high. The stock’s 5-day price performance is -5.30%, and it has moved by 1.52% in 30 days. Based on these gigs, the overall price performance for the year is -10.37%.
The consensus price target of analysts on Wall Street is $5, which implies an increase of 46.4% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $5 and $5 respectively. As a result, DHC is trading at a discount of -86.57% off the target high and -86.57% off the low.
Diversified Healthcare Trust (DHC) estimates and forecasts
In the rating firms’ projections, revenue will increase 8.95% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 385.6M as predicted by 1 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to 386.6M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 370.78M and 371.39M respectively. In this case, analysts expect current quarter sales to grow by 4.00% and then jump by 4.09% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -33.00%.
DHC Dividends
Diversified Healthcare Trust is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Diversified Healthcare Trust is 0.04, with the dividend yield indicating at 1.49 percent, continuing the trend of increasing dividends in recent years.
The next largest institutional holding, with 19.72 million shares, is of VANGUARD GROUP INC’s that is approximately 8.245% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $60.15 million.
Also, the Mutual Funds coming in first place with the largest holdings of Diversified Healthcare Trust (DHC) shares are Vanguard Total Stock Market Index Fund and Vanguard Specialized-Real Estate Index Fund . Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 6.81 shares. This amounts to just over 2.82 percent of the company’s overall shares, with a $18.26 million market value. The same data shows that the other fund manager holds slightly less at 6.65, or about 2.76% of the stock, which is worth about $17.82 million.
